Results 81 to 90 of about 18,455 (220)

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

open access: yesClinical Case Reports, 2018
Key Clinical Message This case is a reminder not to overlook rare causes of electrolyte shifts, which may cause reversible changes in pacemaker pacing thresholds.
Stefan Asbach   +4 more
doaj   +1 more source

Paraganglioma of the thyroid gland: A case report [PDF]

open access: yesVojnosanitetski Pregled, 2014
Introduction. Thyroid paraganglioma is a very rare malignant neuroendocrine tumor. Immunohistochemical features of thyroid paraganglioma are helpful for the diagnosis. Case report.
Filipović Aleksandar   +2 more
doaj   +1 more source

Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount [PDF]

open access: yes, 2014
Background: Targeted radionuclide therapy with high-energy beta-emitters is generally considered suboptimal to cure small tumours (90Y, 177Lu or 213Bi, accounting for the radionuclide specific activities (SAs), the tumour absorbed doses and tumour (radio)
Blois, E. (Erik) de   +8 more
core   +2 more sources

Peptide Receptor Radionuclide Therapy in the United States [PDF]

open access: yesJournal of Nuclear Medicine, 2012
TO THE EDITOR: We read with great interest the article by Drs. Graham and Menda titled “Radiopeptide Imaging and Therapy in the United States” published in the recent supplement to The Journal of Nuclear Medicine ([1][1]).
Peeyush, Bhargava, Ebrahim S, Delpassand
openaire   +2 more sources

Ultrasmall Au10–12 Nanoclusters: A Novel Platform for 223Ra‐Targeted Tumor α‐Therapy

open access: yesExploration, EarlyView.
Encapsulating 223Ra in Au10‐12 nanoclusters and functionalizing them with RGD peptides enables targeted α‐therapy and immune microenvironment remodeling in non‐osseous tumors like triple‐negative breast cancer. This study establishes a foundational framework for novel 223Ra‐labeled α‐radiopharmaceuticals and shows strong potential for clinical ...
Yifei Jiang   +11 more
wiley   +1 more source

Molecular theranostics: principles, challenges and controversies

open access: yesJournal of Medical Radiation Sciences, Volume 72, Issue 1, Page 156-164, March 2025.
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley   +1 more source

Novel small peptides derived from VEGF125-136: potential drugs for radioactive diagnosis and therapy in A549 tumor-bearing nude mice

open access: yesScientific Reports, 2017
Vascular endothelial growth factor receptor (VEGFR) is a critical factor in tumor angiogenesis and has been considered a potential target for receptor-mediated radionuclide imaging and therapy.
Xiang Zhang   +7 more
doaj   +1 more source

Towards a Radio-guided Surgery with $\beta^{-}$ Decays: Uptake of a somatostatin analogue (DOTATOC) in Meningioma and High Grade Glioma

open access: yes, 2014
A novel radio guided surgery (RGS) technique for cerebral tumors using $\beta^{-}$ radiation is being developed. Checking the availability of a radio-tracer that can deliver a $\beta^{-}$ emitter to the tumor is a fundamental step in the deployment of ...
BELLINI, Fabio   +23 more
core   +1 more source

Analysis of iodinated quorum sensing peptides by LC-UV/ESI ion trap mass spectrometry [PDF]

open access: yes, 2018
Five different quorum sensing peptides (QSP) were iodinated using different iodination techniques. These iodinated peptides were analyzed using a C-18 reversed phase HPLC system, applying a linear gradient of water and acetonitrile containing 0.1% (m/v ...
De Spiegeleer, Bart   +5 more
core   +2 more sources

Cutting‐edge advances in bicyclic peptide‐based radiotracers for cancer imaging and theranostics

open access: yesVIEW, EarlyView.
Abstract Along with successful clinical approval of radiopharmaceuticals targeting somatostatin receptor subtype 2 and prostate‐specific membrane antigen, peptide‐based radiotracers have garnered the increasing attention in cancer imaging and theranostics. As a newly emerging targeting ligand in recent years, bicyclic peptides have demonstrated immense
Hengyi Ou, Xiaobo Wang, Fei Kang
wiley   +1 more source

Home - About - Disclaimer - Privacy